286 related articles for article (PubMed ID: 29998546)
1. Examining the dimensionality of the Fear of Cancer Recurrence Inventory.
Galica J; Brennenstuhl S; Maheu C; Townsley C; Metcalfe K
Psychooncology; 2018 Nov; 27(11):2602-2608. PubMed ID: 29998546
[TBL] [Abstract][Full Text] [Related]
2. Exploring the screening capacity of the Fear of Cancer Recurrence Inventory-Short Form for clinical levels of fear of cancer recurrence.
Fardell JE; Jones G; Smith AB; Lebel S; Thewes B; Costa D; Tiller K; Simard S; Feldstain A; Beattie S; McCallum M; ; Butow P
Psychooncology; 2018 Feb; 27(2):492-499. PubMed ID: 28755462
[TBL] [Abstract][Full Text] [Related]
3. Initial validation of the Danish version of the Fear of Cancer Recurrence Inventory (FCRI) in colorectal cancer patients.
Hovdenak Jakobsen I; Jeppesen MM; Simard S; Thaysen HV; Laurberg S; Juul T
J Cancer Surviv; 2018 Dec; 12(6):723-732. PubMed ID: 30128857
[TBL] [Abstract][Full Text] [Related]
4. Re-validation and screening capacity of the 6-item version of the Cancer Worry Scale.
Custers JAE; Kwakkenbos L; van de Wal M; Prins JB; Thewes B
Psychooncology; 2018 Nov; 27(11):2609-2615. PubMed ID: 29843189
[TBL] [Abstract][Full Text] [Related]
5. Measuring fear of cancer recurrence in survivors of childhood cancer: Development and preliminary validation of the Fear of Cancer Recurrence Inventory (FCRI)-Child and Parent versions.
Tutelman PR; Chambers CT; Heathcote LC; Fernandez CV; Flanders A; Patton M; Schulte FSM; Guilcher GMT; Simard S; MacLeod J; Stern M
Psychooncology; 2022 Jun; 31(6):911-919. PubMed ID: 35018689
[TBL] [Abstract][Full Text] [Related]
6. Towards the validation of a new, blended theoretical model of fear of cancer recurrence.
Lebel S; Maheu C; Tomei C; Bernstein LJ; Courbasson C; Ferguson S; Harris C; Jolicoeur L; Lefebvre M; Muraca L; Ramanakumar AV; Singh M; Parrott J; Figueiredo D
Psychooncology; 2018 Nov; 27(11):2594-2601. PubMed ID: 30180279
[TBL] [Abstract][Full Text] [Related]
7. Medical, demographic and psychological correlates of fear of cancer recurrence (FCR) morbidity in breast, colorectal and melanoma cancer survivors with probable clinically significant FCR seeking psychological treatment through the ConquerFear study.
Smith A'; Sharpe L; Thewes B; Turner J; Gilchrist J; Fardell JE; Girgis A; Tesson S; Descallar J; Bell ML; Beith J; Butow P;
Support Care Cancer; 2018 Dec; 26(12):4207-4216. PubMed ID: 29882025
[TBL] [Abstract][Full Text] [Related]
8. Empirical validation of the English version of the Fear of Cancer Recurrence Inventory.
Lebel S; Simard S; Harris C; Feldstain A; Beattie S; McCallum M; Lefebvre M; Savard J; Devins GM
Qual Life Res; 2016 Feb; 25(2):311-321. PubMed ID: 26341969
[TBL] [Abstract][Full Text] [Related]
9. Validity and screening capacity of the FCR-1r for fear of cancer recurrence in long-term colorectal cancer survivors.
Lyhne JD; Smith AB; Timm S; Simard S; Jensen LH; Frostholm L; Fink P
Support Care Cancer; 2023 Nov; 31(12):690. PubMed ID: 37950072
[TBL] [Abstract][Full Text] [Related]
10. Fear of cancer recurrence among survivors of childhood cancer.
Wroot H; Afzal AR; Forbes C; Russell KB; Trepanier L; Patton M; Fidler-Benaoudia M; Reynolds K; Schulte F
Psychooncology; 2020 Jul; 29(7):1132-1140. PubMed ID: 32281171
[TBL] [Abstract][Full Text] [Related]
11. Examining the preliminary efficacy of an intervention for fear of cancer recurrence in female cancer survivors: a randomized controlled clinical trial pilot study.
Tomei C; Lebel S; Maheu C; Lefebvre M; Harris C
Support Care Cancer; 2018 Aug; 26(8):2751-2762. PubMed ID: 29500582
[TBL] [Abstract][Full Text] [Related]
12. The impact of fear of cancer recurrence on healthcare utilization among long-term breast cancer survivors recruited through ECOG-ACRIN trials.
Vachon E; Krueger E; Champion VL; Haggstrom DA; Cella D; Cohee AA
Psychooncology; 2021 Mar; 30(3):279-286. PubMed ID: 33022832
[TBL] [Abstract][Full Text] [Related]
13. The FCR-1: Initial validation of a single-item measure of fear of cancer recurrence.
Rudy L; Maheu C; Körner A; Lebel S; Gélinas C
Psychooncology; 2020 Apr; 29(4):788-795. PubMed ID: 32026563
[TBL] [Abstract][Full Text] [Related]
14. Utilization of health care services in cancer patients with elevated fear of cancer recurrence.
Champagne A; Ivers H; Savard J
Psychooncology; 2018 Aug; 27(8):1958-1964. PubMed ID: 29719072
[TBL] [Abstract][Full Text] [Related]
15. Revision of the fear of cancer recurrence cognitive and emotional model by Lee-Jones et al with women with breast cancer.
Maheu C; Hébert M; Louli J; Yao TR; Lambert S; Cooke A; Black A; Kyriacou J
Cancer Rep (Hoboken); 2019 Aug; 2(4):e1172. PubMed ID: 32721129
[TBL] [Abstract][Full Text] [Related]
16. Fear of cancer recurrence among Chinese cancer survivors: Prevalence and associations with metacognition and neuroticism.
Ng DWL; Kwong A; Suen D; Chan M; Or A; Ng SS; Foo CC; Fielding BFS; Lam WWT
Psychooncology; 2019 Jun; 28(6):1243-1251. PubMed ID: 30932279
[TBL] [Abstract][Full Text] [Related]
17. Beyond the fear that lingers: The interaction between fear of cancer recurrence and rumination in relation to depression and anxiety symptoms.
Liu J; Peh CX; Simard S; Griva K; Mahendran R
J Psychosom Res; 2018 Aug; 111():120-126. PubMed ID: 29935744
[TBL] [Abstract][Full Text] [Related]
18. The sum of all fears: conceptual challenges with measuring fear of cancer recurrence.
Costa DSJ; Smith AB; Fardell JE
Support Care Cancer; 2016 Jan; 24(1):1-3. PubMed ID: 26377307
[TBL] [Abstract][Full Text] [Related]
19. ConquerFear-Group: A randomized controlled trial of an online-delivered group-based psychological intervention for fear of cancer recurrence in breast cancer survivors.
Tauber NM; O'Toole MS; Jensen AB; Butow PN; Thewes B; Elkjaer E; Knutzen S; von Heymann A; Johansen C; Zachariae R
Psychooncology; 2023 Sep; 32(9):1424-1432. PubMed ID: 37489745
[TBL] [Abstract][Full Text] [Related]
20. Factor structure of the Fear of Cancer Recurrence Inventory (FCRI): Comparison of international FCRI factor structure data and factor analysis of the Dutch FCRI-NL using three predominantly breast cancer samples.
van Helmondt SJ; van der Lee ML; Bisseling EM; Lodder P; de Vries J
Eur J Cancer Care (Engl); 2021 Sep; 30(5):e13431. PubMed ID: 33763943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
